Microvesicle-mediated delivery of transforming growth factor β1 siRNA for the suppression of tumor growth in mice
- 1 May 2014
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 35 (14) , 4390-4400
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Functional diversification of Argonautes in nematodes: an expanding universeBiochemical Society Transactions, 2013
- Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNACell Research, 2011
- Identification of Small Molecules That Suppress MicroRNA Function and Reverse TumorigenesisJournal of Biological Chemistry, 2010
- Secreted Monocytic miR-150 Enhances Targeted Endothelial Cell MigrationMolecular Cell, 2010
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer ModelCell, 2009
- Biological Gene Delivery Vehicles: Beyond Viral VectorsMolecular Therapy, 2009
- The promises and pitfalls of RNA-interference-based therapeuticsNature, 2009
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNature Cell Biology, 2008
- Preclinical Studies To Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle BiodistributionMolecular Pharmaceutics, 2008
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature Cell Biology, 2007